Home/Filings/4/0001818382-22-000212
4//SEC Filing

Scheessele William John 4

Accession 0001818382-22-000212

CIK 0001818382other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 7:53 PM ET

Size

4.6 KB

Accession

0001818382-22-000212

Insider Transaction Report

Form 4
Period: 2022-12-13
Scheessele William John
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2022-12-13$3.09/sh+5,000$15,45015,525 total

Issuer

Humacyte, Inc.

CIK 0001818382

Entity typeother

Related Parties

1
  • filerCIK 0001879378

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 7:53 PM ET
Size
4.6 KB